Browsing Tag
Phase 2 trial
10 posts
Incannex Healthcare secures FDA Fast Track designation for IHL-42X in obstructive sleep apnea treatment market
Find out how Incannex Healthcare’s IHL-42X earned FDA Fast Track status and why it could transform oral treatment for obstructive sleep apnea.
AN2 Therapeutics reveals 40% 90-day mortality in NIH-backed melioidosis study, advancing epetraborole toward Phase 2 trial
AN2 Therapeutics reports high 90-day mortality in 200-patient NIH-funded melioidosis study, laying groundwork for Phase 2 epetraborole trial in 2025.
FDA grants Breakthrough Therapy Designation to Lacutamab for Sézary Syndrome
Innate Pharma has achieved a significant regulatory milestone with the U.S. Food and Drug Administration (FDA) granting Breakthrough…
Rallybio Phase 2 trial of RLYB212 begins to tackle FNAIT in high-risk pregnancies
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company known for advancing innovative therapies for rare diseases, has commenced…
OncoVerity accelerates AML treatment with Series A extension
OncoVerity, a leader in integrating bioinformatics with oncology drug development, has closed a Series A extension financing round,…
BirchBioMed reports breakthrough phase 2 trial results for FS2 in treating keloid scars
BirchBioMed, a Canadian clinical-stage immunology company, has unveiled promising results from a phase 2 trial of FS2, its…
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine,…
Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients
Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase…
TWi Biotechnology begins Phase 2 trial for AC-203 in epidermolysis bullosa patients
TWi Biotechnology, a Taiwanese biopharmaceutical company, has initiated the enrollment of patients in a pivotal Phase 2 clinical…
GNI Group to halt enrolment in Phase 2 liver fibrosis trial following positive results
Japanese biotech company GNI Group has announced it will cease enrolment of new patients in its Phase 2…